KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In Process
Ratios

CRISPR Therapeutics AG (CRSP) Long-Term Debt Issuances (2016)

CRISPR Therapeutics AG (CRSP) has disclosed Long-Term Debt Issuances for 1 consecutive years, with $10000.0 as the latest value for Q4 2016.

  • Quarterly Long-Term Debt Issuances changed N/A to $10000.0 in Q4 2016 from the year-ago period, while the trailing twelve-month figure was $35.0 million through Dec 2016, changed N/A year-over-year, with the annual reading at $35.0 million for FY2016, 8.44% down from the prior year.
  • Long-Term Debt Issuances hit $10000.0 in Q4 2016 for CRISPR Therapeutics AG, down from $35.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $35.0 million in Q1 2016 to a low of $10000.0 in Q4 2016.